The Function of PEDF in Recessive Osteogenesis Imperfecta
PEDF在隐性成骨不全症中的作用
基本信息
- 批准号:8500994
- 负责人:
- 金额:$ 5.22万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-08-01 至 2015-07-31
- 项目状态:已结题
- 来源:
- 关键词:Angiogenesis InhibitorsBiologicalBloodBone Mineralization Regulation PathwayCalvariaChondrocytesClinicalCodeCollagenCollagen Type IDataDefectExhibitsExtracellular MatrixFellowshipFishesGene ExpressionGenesGenetic ModelsGoalsHereditary DiseaseHomeostasisHumanHuman GeneticsInheritedKnockout MiceLaboratoriesLeadMediatingModelingMolecularMusMutationOsteoblastsOsteoclastsOsteocytesOsteogenesis ImperfectaOsteoidOsteomalaciaPatientsPatternPhenotypePhysiologic calcificationProcessProtease InhibitorProteinsRecombinantsResearchRoleSerpinsSeveritiesSignal PathwaySignal TransductionStreamTestingTherapeuticTherapeutic EffectTransgenic MiceVirusangiogenesisbasebonebone masscell typeeffective therapygain of functionhelper-dependent adenoviral vectorin vivoloss of function mutationmembermineralizationmouse modelneuron developmentnew therapeutic targetnovelnull mutationpigment epithelium-derived factorskeletalskeletal tissuetherapeutic development
项目摘要
DESCRIPTION (provided by applicant): Osteogenesis Imperfecta (OI) is the most common form of brittle bone disease and displays a spectrum of severity from mild phenotypes to severe early lethality. Key clinical features of OI are bone fragility and low bone mass. This fellowship focuses on a gene, SERPINF1 (serpin peptidase inhibitor, clade F, member 1), in which mutations cause a unique form of OI (type VI). OI type VI is characterized by un- mineralized osteoid and the fish-scale pattern of bone lamellation, which are pathologically distinct from other forms of OI. SERPINF1 encodes pigment epithelium-derived factor (PEDF) which is extensively studied as an anti-angiogenic, neurotrophic, and neuroprotective factor. Although PEDF is expressed in major cell types of skeletal tissue including osteoblasts, osteoclasts, and chondrocytes, its function in bone homeostasis is unknown. Therefore, the goal of this proposal is to elucidate the role of PEDF in bone homeostasis and determine the mechanism by which null mutations of this gene lead to OI type VI. I will also evaluate the therapeutic potential of exogenously delivered PEDF using mouse models. In the preliminary data, PEDF knockout mice show reduced bone volume and increased the expression level of MEPE, a negative regulator of bone mineralization. Based on preliminary data, I hypothesize that loss of PEDF alters intracellular signaling which regulates the function of osteoblasts and osteocytes, thus resulting in abnormal bone mineralization. I will test this hypothesis by investigating the PEDF loss- and gain-of-function mouse models and by evaluating cell signaling defects in the absence of PEDF. This research will not only elucidate a novel regulatory mechanism for bone mineralization, but also establish the pathogenic mechanism of OI type VI, thus providing potential therapeutic strategies for patients with OI type VI.
描述(由申请人提供):成骨不全症(Osteogenesis Imperfecta, OI)是最常见的脆性骨病,表现出从轻度表型到严重的早期致死率的严重程度。成骨不全的主要临床特征是骨脆性和低骨量。这项研究的重点是一个基因,serinf1(丝氨酸肽酶抑制剂,进化支F,成员1),其突变导致一种独特形式的OI (VI型)。VI型成骨不全以非矿化的类骨和鱼鳞状骨片状为特征,在病理上与其他形式的成骨不全不同。serinf1编码色素上皮衍生因子(PEDF), PEDF作为抗血管生成、神经营养和神经保护因子被广泛研究。尽管PEDF在骨组织的主要细胞类型中表达,包括成骨细胞、破骨细胞和软骨细胞,但其在骨稳态中的功能尚不清楚。因此,本提案的目标是阐明PEDF在骨稳态中的作用,并确定该基因的零突变导致VI型成骨不全的机制。我还将利用小鼠模型评估外源性PEDF的治疗潜力。在初步数据中,PEDF敲除小鼠表现出骨体积减小和骨矿化负调节因子MEPE表达水平升高。根据初步数据,我推测PEDF的缺失改变了细胞内信号传导,从而调节成骨细胞和骨细胞的功能,从而导致骨矿化异常。我将通过研究PEDF缺失和功能获得的小鼠模型以及评估PEDF缺失时的细胞信号缺陷来验证这一假设。本研究不仅将阐明骨矿化的新调控机制,还将建立VI型成骨不全的致病机制,从而为VI型成骨不全患者提供潜在的治疗策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kyu Sang Joeng其他文献
Kyu Sang Joeng的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kyu Sang Joeng', 18)}}的其他基金
The function of mTORC1/Stat3 signaling in the regulation of fibrovascular scar formation during tendon healing
mTORC1/Stat3信号在肌腱愈合过程中纤维血管疤痕形成调节中的作用
- 批准号:
10444013 - 财政年份:2022
- 资助金额:
$ 5.22万 - 项目类别:
The function of mTORC1/Stat3 signaling in the regulation of fibrovascular scar formation during tendon healing
mTORC1/Stat3信号在肌腱愈合过程中纤维血管疤痕形成调节中的作用
- 批准号:
10554422 - 财政年份:2022
- 资助金额:
$ 5.22万 - 项目类别:
Identification of the Molecular Interaction Between Joint Tissues as a Pathophysiological Mechanism of Osteoarthritis
鉴定关节组织之间的分子相互作用作为骨关节炎的病理生理机制
- 批准号:
9898301 - 财政年份:2018
- 资助金额:
$ 5.22万 - 项目类别:
Identification of the molecular interaction between joint tissues as a pathophysiological mechanism of osteoarthritis
鉴定关节组织之间的分子相互作用作为骨关节炎的病理生理机制
- 批准号:
9240581 - 财政年份:2016
- 资助金额:
$ 5.22万 - 项目类别:
The Function of PEDF in Recessive Osteogenesis Imperfecta
PEDF在隐性成骨不全症中的作用
- 批准号:
8392518 - 财政年份:2012
- 资助金额:
$ 5.22万 - 项目类别:
相似海外基金
investigation of novel biomarkers for depression by multi-omics analysis of the human biological hippocampus and blood samples
通过对人类生物海马体和血液样本进行多组学分析来研究抑郁症的新型生物标志物
- 批准号:
23K14804 - 财政年份:2023
- 资助金额:
$ 5.22万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Biological function of osteoporotic drugs on bone-specific blood vessels and perivascular cells
骨质疏松药物对骨特异性血管和血管周围细胞的生物学功能
- 批准号:
22K21006 - 财政年份:2022
- 资助金额:
$ 5.22万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Establishment of blood-based biomarkers to reflect age-related changes in biological membrane
建立基于血液的生物标志物以反映生物膜与年龄相关的变化
- 批准号:
22K19762 - 财政年份:2022
- 资助金额:
$ 5.22万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Biological effects of bisphosphonates on bone-specific blood vessels and perivascular cells
双膦酸盐对骨特异性血管和血管周围细胞的生物学效应
- 批准号:
22K17000 - 财政年份:2022
- 资助金额:
$ 5.22万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Development of blood-brain barrier-crossing antibodies utilizing the biological features of glucose transporters
利用葡萄糖转运蛋白的生物学特性开发血脑屏障跨越抗体
- 批准号:
21K18268 - 财政年份:2021
- 资助金额:
$ 5.22万 - 项目类别:
Grant-in-Aid for Challenging Research (Pioneering)
Biological action of PTH/PTHrP on bone-specific blood vessels and osteo-vascular interaction
PTH/PTHrP 对骨特异性血管和骨血管相互作用的生物学作用
- 批准号:
21H03103 - 财政年份:2021
- 资助金额:
$ 5.22万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Molecular biological analysis on peripheral blood and pharyngeal mucosa of Kawasaki disease children
川崎病患儿外周血及咽黏膜的分子生物学分析
- 批准号:
16K10042 - 财政年份:2016
- 资助金额:
$ 5.22万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
HHSN2612012000151/HHSN2610006Base Contract Title: Preclinical Efficacy and Intermediate Biomarkers. Task Order Title: Modulation of miRNA Expression in Blood or Other Biological Fluids Compared wi
HHSN2612012000151/HHSN2610006基本合同标题:临床前功效和中间生物标志物。
- 批准号:
8947461 - 财政年份:2014
- 资助金额:
$ 5.22万 - 项目类别:
Development of Off-the-shelf Completely Biological Small-Diameter Blood Vessel wi
现成的全生物小直径血管的开发
- 批准号:
8497217 - 财政年份:2013
- 资助金额:
$ 5.22万 - 项目类别:
Establishment of the mesureing system for early diagnosis of Alzheimer's disease using blood biological markers.
建立利用血液生物标志物早期诊断阿尔茨海默病的测量系统。
- 批准号:
23790990 - 财政年份:2011
- 资助金额:
$ 5.22万 - 项目类别:
Grant-in-Aid for Young Scientists (B)